Skip to main content
SpringerLink
Log in

The Role of Clinical Observation: Red Flag 1 — Cardiomyopathies and Skeletal Muscle Involvement

  • Chapter
Genetic Cardiomyopathies

  • 813 Accesses

Abstract

Genetic mutations can cause specific changes to cardiomyopathy (CMP) phenotype, and these changes may be associated with a variety of abnormalities of different organs and systems. Therefore, the clinical approach is very important, as is the presence of “red flags”, which are potentially useful for better characterization of the genetic background of the CMP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McNally EM, MacLeod H (2005) Therapy insight: cardiovascular complications associated with muscular dystrophies. Nat Clin Pract Cardiovasc Med 2:301–308. doi:10.1038/ncpcar-dio0213

    Article  PubMed  CAS  Google Scholar 

  2. Taylor MR, Fain PR, Sinagra G et al (2003) Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41:771–780

    Article  PubMed  CAS  Google Scholar 

  3. Lapidos KA, Kakkar R, McNally EM (2004) The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94:1023–1031. doi:10.1161/01.RES.0000126574.61061.25

    Article  PubMed  CAS  Google Scholar 

  4. Brooke MH, Fenichel GM, Griggs RC et al (1989) Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 39:475–481

    Article  PubMed  CAS  Google Scholar 

  5. Jefferies JL, Eidem BW, Belmont JW et al (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799–2804. doi:10.1161/CIR-CULATIONAHA. 104.528281

    Article  PubMed  Google Scholar 

  6. Melacini P, Fanin M, Danieli GA et al (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker’s muscular dystrophy. Circulation 94:3168–3175

    Article  PubMed  CAS  Google Scholar 

  7. Mestroni L, Miyamoto SD, Taylor MR (2007) Genetics of dilated cardiomyopathy conduction disease. Prog Pediatr Cardiol 24:3–13

    Article  Google Scholar 

  8. Mirabella M, Servidei S, Manfredi G et al (1993) Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology 43:2342–2345

    Article  PubMed  CAS  Google Scholar 

  9. Politano L, Nigro V, Nigro G et al (1996) Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 275:1335–1338

    Article  PubMed  CAS  Google Scholar 

  10. Arbustini E, Diegoli M, Morbini P et al (2000) Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35:1760–1768

    Article  PubMed  CAS  Google Scholar 

  11. Tsubata S, Bowles KR, Vatta M et al (2000) Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 106:655–662. doi:10.1172/JCI9224

    Article  PubMed  CAS  Google Scholar 

  12. Sylvius N, Duboscq-Bidot L, Bouchier C et al (2003) Mutational analysis of the beta-and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet A 120A:8–12. doi:10.1002/ajmg.a.20003

    Article  PubMed  Google Scholar 

  13. Barresi R, Di Blasi C, Negri T et al (2000) Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet 37:102–107

    Article  PubMed  CAS  Google Scholar 

  14. Melacini P, Fanin M, Duggan DJ et al (1999) Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 22:473–479

    Article  PubMed  CAS  Google Scholar 

  15. Gerull B, Gramlich M, Atherton J et al (2002) Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 30:201–204. doi: 10.1038/ng815

    Article  PubMed  CAS  Google Scholar 

  16. Satoh M, Takahashi M, Sakamoto T et al (1999) Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 262:411–417. doi:10.1006/bbrc.1999.1221

    Article  PubMed  CAS  Google Scholar 

  17. Carmignac V, Salih MA, Quijano-Roy S et al (2007) C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol 61:340–351. doi:10.1002/ana.21089

    Article  PubMed  CAS  Google Scholar 

  18. Sylvius N, Tesson F (2006) Lamin A/C and cardiac diseases. Curr Opin Cardiol 21:159–165. doi:10.1097/01.hco.0000221575.33501.58

    Article  PubMed  Google Scholar 

  19. Karkkainen S, Helio T, Miettinen R et al (2004) A novel mutation, Ser143Pro, in the lamin A/C gene is common in Finnish patients with familial dilated cardiomyopathy. Eur Heart J 25:885–893.doi:10.1016/j.ehj.2004.01.020

    Article  PubMed  Google Scholar 

  20. Emery AE, Dreifuss FE (1966) Unusual type of benign x-linked muscular dystrophy. J Neurol Neurosurg Psychiatry 29:338–342

    Article  PubMed  CAS  Google Scholar 

  21. Bonne G, Di Barletta R, Varnous et al (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285–288. doi: 10.1038/6799

    Article  PubMed  CAS  Google Scholar 

  22. Raffaele Di Barletta M, Ricci E et al (2000) Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 66:1407–1412. doi:10.1086/302869

    Article  Google Scholar 

  23. Brodsky GL, Muntoni F, Miocic S et al (2000) Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101:473–476

    Article  PubMed  CAS  Google Scholar 

  24. Fatkin D, MacRae C, Sasaki T et al (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341:1715–1724. doi:10.1056/NEJM199912023412302

    Article  PubMed  CAS  Google Scholar 

  25. van der Kooi AJ, Bonne G, Eymard B et al (2002) Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 59:620–623

    Article  PubMed  Google Scholar 

  26. Caux F, Dubosclard E, Lascols O et al (2003) A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 88:1006–1013

    Article  PubMed  CAS  Google Scholar 

  27. Sakata K, Shimizu M, Ino H et al (2005) High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation 111:3352–3358. doi:10.1161/CIRCULATIONAHA.104.527184

    Article  PubMed  Google Scholar 

  28. Yoshioka M, Saida K, Itagaki Y, Kamiya T (1989) Follow up study of cardiac involvement in Emery-Dreifuss muscular dystrophy. Arch Dis Child 64:713–715

    Article  PubMed  CAS  Google Scholar 

  29. Rees W, Schuler S, Hummel M, Hetzer R (1993) Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy. J Heart Lung Transplant 12:804–807

    PubMed  CAS  Google Scholar 

  30. Cartegni L, di Barletta MR, Barresi R et al (1997) Heart-specific localization of emerin: new insights into Emery-Dreifuss muscular dystrophy. Hum Mol Genet 6:2257–2264

    Article  PubMed  CAS  Google Scholar 

  31. Buckley AE, Dean J, Mahy IR (1999) Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 82:105–108

    PubMed  CAS  Google Scholar 

  32. Murakami T, Hayashi YK, Noguchi S et al (2006) Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol 60:597–602. doi:10.1002/ana.20973

    Article  PubMed  CAS  Google Scholar 

  33. GeneTests: Medical Genetics Information Resource (1993–2010) University of Washington, Seattle. http://www.genetests.org. Accessed 8 May 2012

  34. Miura K, Shirasawa H (1987) Congenital muscular dystrophy of the Fukuyama type (FCMD) with severe myocardial fibrosis. A case report with postmortem angiography. Acta Pathol Jpn 37:1823–1835

    PubMed  CAS  Google Scholar 

  35. Osawa M, Arai Y, Ikenaka H et al (1991) Fukuyama type congenital progressive muscular dystrophy. Acta Paediatr Jpn 33:261–269

    Article  PubMed  CAS  Google Scholar 

  36. Groh WJ, Groh MR, Saha C et al (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358:2688–2697. doi: 10.1056/NEJMoa062800

    Article  PubMed  CAS  Google Scholar 

  37. von zur Muhlen F, Klass C, Kreuzer H et al (1998) Cardiac involvement in proximal myotonic myopathy. Heart 79:619–621

    Google Scholar 

  38. Shen EN, Madsen T (1991) Facioscapulohumeral muscular dystrophy and recurrent pacemaker lead dislodgement. Am Heart J 122:1167–1169

    Article  PubMed  CAS  Google Scholar 

  39. Laforet P, de Toma C, Eymard B et al (1998) Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology 51:1454–1456

    Article  PubMed  CAS  Google Scholar 

  40. Selcen D, Muntoni F, Burton BK et al (2009) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65:83–89. doi:10.1002/ana.21553

    Article  PubMed  CAS  Google Scholar 

  41. Reilich P, Schoser B, Schramm N et al (2010) The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy. Neuromuscul Disord 20:255–259. doi:10.1016/j.nmd.2010.01.012

    Article  PubMed  Google Scholar 

  42. Dalakas MC, Park KY, Semino-Mora C et al (2000) Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 342:770–780. doi:10.1056/NEJM200003163421104

    Article  PubMed  CAS  Google Scholar 

  43. Li D, Tapscoft T, Gonzalez O et al (1999) Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100:461–464

    Article  PubMed  CAS  Google Scholar 

  44. Taylor MR, Slavov D, Ku L et al (2007) Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 115:1244–1251. doi:10.1161/CIRCULATIONAHA.106.646778

    Article  PubMed  CAS  Google Scholar 

  45. Vatta M, Mohapatra B, Jimenez S et al (2003) Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 42:2014–2027

    Article  PubMed  CAS  Google Scholar 

  46. Arimura T, Hayashi T, Terada H et al (2004) A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J Biol Chem 279:6746–6752. doi:10.1074/jbc.M311849200

    Article  PubMed  CAS  Google Scholar 

  47. Selcen D, Engel AG (2005) Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 57:269–276. doi:10.1002/ana.20376

    Article  PubMed  CAS  Google Scholar 

  48. Hauser MA, Horrigan SK, Salmikangas P et al (2000) Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet 9:2141–2147

    Article  PubMed  CAS  Google Scholar 

  49. Selcen D, Engel AG (2004) Mutations in myotilin cause myofibrillar myopathy. Neurology 62:1363–1371

    Article  PubMed  CAS  Google Scholar 

  50. Bagneris C, Bateman OA, Naylor CE et al (2009) Crystal structures of alpha-crystallin domain dimers of alphaB-crystallin and Hsp20. J Mol Biol 392:1242–1252. doi: 10.1016/j.jmb.2009.07.069

    Article  PubMed  CAS  Google Scholar 

  51. Wang X, Klevitsky R, Huang W et al (2003) AlphaB-crystallin modulates protein aggregation of abnormal desmin. Circ Res 93:998–1005. doi:10.1161/01.RES.0000102401.77712.ED

    Article  PubMed  CAS  Google Scholar 

  52. Pilotto A, Marziliano N, Pasotti M et al (2006) alphaB-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands. Biochem Biophys Res Commun 346:1115–1117. doi:10.1016/j.bbrc.2006.05.203

    Article  PubMed  CAS  Google Scholar 

  53. Sacconi S, Feasson L, Antoine JC et al (2012) A novel CRYAB mutation resulting in multisystemic disease. Neuromuscul Disord 22:66–72. doi:10.1016/j.nmd.2011.07.004

    Article  PubMed  Google Scholar 

  54. Fitzpatrick AP, Shapiro LM, Rickards AF et al (1990) Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 63:114–118

    Article  PubMed  CAS  Google Scholar 

  55. Katritsis D, Wilmshurst PT, Wendon JA et al (1991) Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 18:1230–1235

    Article  PubMed  CAS  Google Scholar 

  56. Ishiwata S, Nishiyama S, Seki A, Kojima S (1993) Restrictive cardiomyopathy with complete atrio ventricular block and distal myopathy with rimmed vacuoles. Jpn Circ J 57:928–933

    Article  PubMed  CAS  Google Scholar 

  57. Milasin J et al (1996) Apoint mutation in the 54 splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Human Molecular Genetics 5(1):73–79

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Department, Ospedali Riuniti and University of Trieste, Italy

    Gianfranco Sinagra

Authors
  1. Gianfranco Sinagra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fulvio Camerini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Enrico Fabris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianfranco Sinagra .

Editor information

Editors and Affiliations

  1. Department and Postgraduate School of Cardiovascular Sciences, Ospedali Riuniti and University of Trieste, Italy

    Gianfranco Sinagra MD, FESC (Professor of Cardiology Chief of Cardiovascular) (Professor of Cardiology Chief of Cardiovascular)

  2. Cardiovascular Institute, University of Colorado Denver Anschutz, Medical Campus, Aurora, USA

    Luisa Mestroni MD, FACC, FESC (Professor of Cardiology Director Molecular Genetics) (Professor of Cardiology Director Molecular Genetics)

  3. Ospedali Riuniti and University of Trieste, Italy

    Fulvio Camerini MD, EFESC (Professor of Cardiology) (Professor of Cardiology)

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Sinagra, G., Camerini, F., Fabris, E. (2013). The Role of Clinical Observation: Red Flag 1 — Cardiomyopathies and Skeletal Muscle Involvement. In: Sinagra, G., Mestroni, L., Camerini, F. (eds) Genetic Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2757-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2757-2_3

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2756-5

  • Online ISBN: 978-88-470-2757-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation